U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07166939) titled '45th Multicenter Airway Research Collaboration' on Sept. 09.
Brief Summary: The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Asthma Acute
Asthma Exacerbation
Asthma
Asthma Control Level
Intervention:
DRUG: Airsupra
1 dose (2 inhalations) PRN, with maximum of 6 doses (12 inhalations) in a 24-hour period
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Massachusetts General Hospital
Information pro...